Artificial Intelligence and Hepatocellular Carcinoma

Summary

To identify new relevant biomarkers for HCC patients and their risk of recurrence. Radiomics data and computer-vision data will be explored for their ability to predict the presence of particular pathological signs of aggressiveness (microvascular invasion and satellitosis), and the prognosis after surgery.

Conditions

• HCC

Interventions

DIAGNOSTIC_TEST

CT Scan Radiomics Features Extraction

Extraction of CT radiomics data through AI

Sponsors & Collaborators

• San Gerardo Hospital

  collaborator OTHER

• Ospedale "Carlo Poma" - Mantova

  collaborator OTHER

• Ospedale Centrale di Bolzano

  collaborator UNKNOWN

• University of Pavia

  collaborator OTHER

• Morgagni Pierantoni Hospital

  collaborator OTHER

• Regina Elena Cancer Institute

  collaborator OTHER

• Universita di Verona

  collaborator OTHER

• University of Milano Bicocca

  collaborator OTHER

• Treviso Regional Hospital

  collaborator NETWORK

• Fondazione Policlinico Universitario Agostino Gemelli IRCCS

  collaborator OTHER

• Miulli General Hospital

  collaborator OTHER

• Federico II University

  collaborator OTHER

• Research Institute Against Digestive Cancer IRCAD

  collaborator UNKNOWN

• Humanitas Clinical and Research Center

  lead OTHER

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-07-01

Primary Completion

2022-01-01

Completion

2025-11-01

Countries

• Italy

Study Locations